Electrochemotherapy compared to surgery for treatment of canine mast cell tumours

In Vivo

Volumn 23, Issue 1, 2009, Pages 55-62

  Kodre, Veronika ^a   Cemazar, Maja ^b   Pecar, Jani ^c   Sersa, Gregor ^b   Cör, Andrej ^c   Tozon, Natasa ^c  

^a Janssen Cilag   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cisplatin; Dog; Electrochemotherapy; Electroporation; Mast cell tumour

Indexed keywords

CISPLATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOG; DOG DISEASE; ELECTROCHEMOTHERAPY; FEMALE; INTERMETHOD COMPARISON; LOCAL THERAPY; MALE; MASTOCYTOMA; NONHUMAN; SAFETY; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR NECROSIS; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; DOG DISEASES; DOGS; ELECTROCHEMOTHERAPY; ELECTROPORATION; FEMALE; MALE; MASTOCYTOMA; NEOPLASM STAGING; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 63049097244     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Thamm DH and Vail DM: Mast cell tumors. In: Small Animal Clinical Oncology. 4th ed. Withrow S and MacEwen EWB (eds.). Philadelphia, W.B. Saunders, pp. 402-424, 2007.
2. Murphy S: Mast cell tumours. In: BSAVA Manual of Canine and Feline Oncology. 2nd edn. Dobson JM and Lascelles BDX (eds.). Gloucester, BSAVA, pp. 161-167, 2003.
3. Weisse C, Shofer FS and Soremne K: Recurrence rates and site for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Animal Hosp Assoc 38: 71-73, 2002.
4. Michels GM, Knapp DW, DeNicola DB, Glickman N and Bonney P: Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. J Am Anim Hosp Assoc 38: 458-466, 2002.
5. Seguin B, Leibman NF, Bregazzi VS, Ogilive GK, Powers BE, Dernell WS, Fettman MJ and Withrow SJ: Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 218: 1120-1123, 2001.
6. Murphy S, Sparkes AH, Smith KC, Blunden AS and Brearley MJ: Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Vet Rec 12: 743-746, 2004.
7. Fulcher RP, Ludwig LL, Bergman PJ, Newman SJ, Simpson AM and Patnaik AK: Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 15: 210-215, 2006.
8. Seguin B, Besancon MF, McCallan JL, Dewe LL, Tenwolde MC, Wong EK and Kent MS: Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002). J Vet Inter Med 20: 933-940, 2006.
9. McCaw DL, Miller MA, Ogilive GE, Withrow SJ, Brewer WGJr, Klein MK, Bell FW and Anderson SK: Response of canine cutaneous mast cell tumors to treatment with oral prednisone. J Vet Intern Med 8: 406-408, 1994.
10. McCaw DL, Miller MA, Bergman PJ, Withrow SJ, Moore AS, Knapp DW, Fowler D and Johnson JC: Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med 11: 375-378, 1997.
11. Thamm DH, Mauldin EA and Vail DM: Prednisone and vinblastin chemotherapy for canine mast cell tumor: 41 cases (1992-1997). J Vet Intern Med 13: 491-497, 1999.
12. Rassnick KM, Moor AS, Williams LE, London CA, Kintzer PP, Engler SJ and Cotter SM: Treatment of canine mast cell tumors with CCNU (Lomustine). J Vet Intern Med 13: 601-605, 2004.
13. Gerritson RJ, Teske E, Kraus JS and Rutteman GR: Multiagent chemotherapy for mast cell tumors in dogs. Vet Quart 20: 28-31, 1998.
14. Chun R, Garrett LD and Vail DM: Cancer chemotherapy. In: Small Animal Clinical Oncology. 4th ed. Withrow S and MacEwen EWB (eds.). Philadelphia, W.B. Saunders, pp. 163-192, 2007.
15. Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, Geertsen P, Rudolf Z, O'Sullivan GC and Marty M: Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systematically or locally and electric pulses delivered by the Cliniporator by means of invasive or non-invasive electrodes. EJC Suppl 4: 14-25 2006.
16. Sersa G: The state-of-the-art of electrochemotherapy before the ESOPE study; advantages and clinical uses. EJC Suppl 4: 52-59, 2006.
17. Sersa G, Cemazar M, Parkins CS and Chaplin DJ: Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 35: 672-677, 1999.
18. Sersa G, Jarm T, Kotnik T, Cör A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A and Cemazar M: Vascular disrupting action of electroporation and electrochemo-therapy with bleomycin in murine sarcoma. Brit J Cancer 98: 388-398, 2008.
19. Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D, Lowe R and Teissie J: Electrochemotherapy in veterinary oncology. J Vet Intern Med 22: 826-831, 2008.
20. Mir LM, Devauchelle P, Quintin-Colonna F, Delisie F, Doliger S, Fradelizi D, Belehradek J Jr and Orlowski S: First clinical trial of cat soft tissue sarcomas treatment by electrochemo-therapy. Brit J Cancer 76: 1617-1622, 1997.
21. Spugnini EP and Porrello A: Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of biphasic electric pulses. J Exp Clin Cancer Res 22: 571-580, 2003.
22. Spugnini EP, Vincenti B, Baldi F, Citro G and Baldi A: Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors. Anticancer Res 26: 4585-4590, 2006.
23. Spugnini EP, Dragonetti E, Vincenzi B, Onori N, Citro G and Baldi A: Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma. Melanoma Res 16: 23-27, 2006.
24. Spugnini EP, Baldi A and Vincenzi B: Intraoperative versus postoperative electrochemotherapy in high-grade soft tissue sarcomas: a preliminary study in a spontaneous feline model. Cancer Chemoth Pharm 59: 375-381, 2007.
25. Rols MP, Tamzali Y and Teissie J: Electrochemotherapy of horses. A preliminary clinical report, Bioelectrochem 55: 101-105, 2002.
26. Tozon N, Sersa G and Cemazar M: Electrochemotherapy: Potentation of local antitumour effectivness of cisplatin in dogs and cats. Anticancer Res 21: 2483-2486, 2001.
27. Tozon N, Kodre V, Sersa G and Cemazar M: Effective treatment of perianal tumors in dogs with electrochemotherapy. Anticancer Res 25: 839-846, 2005.
28. Tamzali Y, Teissie J and Rols MP: Cutaneous tumor treatment by electrochemotherapy: preliminary clinical results in horse sarcoids. Rev Med Vet 152: 605-609, 2001.
29. Tamzali Y, Teissie J and Rols MP: First horse sarcoid treatment by electrochemotherapy: Preliminary experimental results. AEEP Proc 49: 381-384, 2003.
30. Raskin RE: Skin and subcutaneous tissues. In: Atlas of Canine and Feline Cytology. 1st ed. Rskin RE and Meyer DJ (eds.). Philadelphia, W.B. Saunders, pp. 35-92, 2001.
31. Patnaik AK, Ehler WY and MacEwen EG: Canine cutaneous mast cell tumors: morphological grading and survival in 83 dogs. Vet Pathol 21: 469-474, 1984.
32. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, WHO Offset Publications 48: 22-27, 1997.
33. Simoes JPC, Schoning P and Butine M: Prognosis of canine mast cell tumors: a comparation of three methods. Vet Pathol 31: 637-647, 1994.
34. Fox LE: Mast cell tumors. In: Cancer in Dogs and Cats. 1st ed. Morrison WB (ed.). Baltimore, Williams & Wilkins, pp. 477-486, 1998.
35. Sersa G, Cemazar M, Miklavcic D and Rudolf Z: Electrochemo-therapy of tumours. Radiol Oncol 40: 163-174, 2006.
36. Sersa G, Stabuc B, Cemazar M, Miklavcic D and Rudolf Z: Electrochemotherapy with cisplatin: Clinical experience in malignant melanoma patients. Clin Cancer Res 6: 863-867, 2000.